The short answer
MOTS-c is a 16-amino-acid peptide encoded by a short open reading frame nested within the 12S ribosomal RNA gene of the mitochondrial genome. Identified in 2015, it activates AMP-activated protein kinase through inhibition of the folate cycle, and translocates to the nucleus under metabolic stress to regulate nuclear gene expression.
Key facts
- Full name
- Mitochondrial ORF of the 12S rRNA type-c
- Length
- 16 amino acids
- Sequence
- H-MRWQEMGYIFYPRKLR-OH
- Molecular weight
- 2,174.6 Da
- Molecular formula
- C101H152N28O22S2
- CAS number
- 1627580-64-6
- PubChem CID
- 146675088
- Identified
- 2015: Lee et al., Cell Metabolism
What makes MOTS-c unusual
Almost every peptide studied in this field is encoded in nuclear DNA and translated in the cytosol. MOTS-c is not. Its coding sequence sits inside the mitochondrial genome, specifically within the 12S ribosomal RNA gene, in a short open reading frame that overlaps a gene already doing another job. That places it in a small class of mitochondrial-derived peptides, and it means the mitochondrion is acting as a signalling organelle rather than only a site of energy metabolism.
Where it came from
MOTS-c was identified by Changhan Lee, Jiali Zeng, Brian Drew and colleagues at the University of Southern California, published in Cell Metabolism on 3 March 2015 under the title 'The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance' (PMID 25738459). The paper described both the peptide and its metabolic effects in mouse models.
Research material referenced
MOTS-C 10mg, third-party HPLC tested
How it signals
MOTS-c activates AMP-activated protein kinase, but not through the canonical route of a rising AMP-to-ATP ratio. It inhibits the folate cycle and de novo purine biosynthesis, which causes AICAR (5-aminoimidazole-4-carboxamide ribonucleotide, an endogenous AMPK activator) to accumulate. AMPK activation follows from that accumulation. Downstream effects reported in the literature include GLUT4 translocation.
The nuclear finding
In 2018 the same group reported something less expected: under metabolic stress, MOTS-c moves from the mitochondrion into the nucleus and regulates nuclear gene expression, including antioxidant response element-containing genes (Kim, Son and Benayoun, Cell Metabolism, 4 September 2018, PMID 29983246). A peptide encoded in mitochondrial DNA that acts on nuclear transcription is a real two-way channel between the two genomes.
The exercise connection
Reynolds and colleagues reported in Nature Communications on 20 January 2021 (PMID 33473109) that MOTS-c is exercise-induced, with skeletal-muscle levels rising roughly 12-fold and circulating levels about 1.6-fold in humans following exercise. The paper characterised it as a regulator of age-dependent physical decline and muscle homeostasis, with the interventional work conducted in mice.
Where the literature stands
MOTS-c appears in roughly 250 indexed PubMed records. The great majority are preclinical (cell models and rodent studies), alongside human observational work on circulating concentrations. It is not an approved medicine in any jurisdiction and is supplied for laboratory research only.
Frequently asked questions
What does MOTS-c stand for?
Mitochondrial Open Reading Frame of the 12S rRNA type-c, which describes exactly where in the mitochondrial genome its coding sequence sits.
Is MOTS-c a hormone?
It is often described as one because it is released and acts at a distance, but it is more accurately a mitochondrial-derived signalling peptide. The distinction matters mainly because its origin is mitochondrial DNA rather than the nuclear genome.
Is MOTS-c approved for any use?
No. It holds no marketing authorisation anywhere and is supplied for laboratory research only.
Is MOTS-c on the WADA prohibited list?
Yes. It is prohibited in sport, which is worth knowing for anyone whose research context involves competitive athletes.
Continue researching
Related guides and reference material.
Primary sources & clinical trials
Published papers, trial registrations, regulator pages and company announcements. Links open the original.
- PubMedLee C et al., Cell Metabolism 2015 (PMID 25738459)pubmed.ncbi.nlm.nih.gov
- PubMedKim KH et al., Cell Metabolism 2018 (PMID 29983246)pubmed.ncbi.nlm.nih.gov
- PubMedReynolds JC et al., Nature Communications 2021 (PMID 33473109)pubmed.ncbi.nlm.nih.gov
- PubChemPubChem · MOTS-c (CID 146675088)pubchem.ncbi.nlm.nih.gov
Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).
Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.
More MOTS-c (Mitochondrial Peptide) articles
- What Is a Mitochondrial-Derived Peptide?Humanin, MOTS-c and the SHLPs are encoded in mitochondrial DNA rather than the nucleus. Why that matters, and how they were found hiding inside rRNA genes.
- MOTS-c Structure, Sequence and Physical PropertiesMOTS-c is H-MRWQEMGYIFYPRKLR-OH, 16 residues, 2,174.6 Da, formula C101H152N28O22S2. Sequence features, charge, and why the methionines matter for handling.
- MOTS-c Mechanism: AMPK Activation via the Folate CycleMOTS-c activates AMPK indirectly, by inhibiting the folate cycle and de novo purine synthesis so AICAR accumulates. Why that differs from metformin and AMP.
- MOTS-c Nuclear Translocation Under Metabolic StressIn 2018 MOTS-c was shown to move into the nucleus under metabolic stress and regulate antioxidant response element genes - retrograde signalling from mtDNA.
- MOTS-c and Exercise: What the Published Research ShowsReynolds et al. reported MOTS-c rises about 12-fold in human skeletal muscle after exercise and 1.6-fold in circulation. What the 2021 paper actually found.